[Therapy of hyperlipoproteinemia. Additive effect of the lipid-lowering agent d-triiodothyronine during dietetic treatment]. 1979

H Wilke, and B Regler, and R Keymling, and H Frahm

Combined treatment of hyperlipidaemia with a 1000-calorie-diet and d-triiodothyronine resulted in a lowering of serum cholesterol, triglycerids and lipoproteins. Concerning cholesterol and beta-lipoproteins there was an addition of reducing effects of simultaneous dietary and drug treatment. Triglycerids are influenced by the combined treatment or by dietary treatment alone to the same extent. The levels of free fatty acids rise during combined treatment while there is no change by diet alone. These observations indicate a most successful lowering of cholesterol and beta-lipoproteins by the combined therapy, but there is an increase of free fatty acids as a metabolic side effect of d-triiodothyronine.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D004038 Diet, Reducing A diet designed to cause an individual to lose weight. Weight Loss Diet,Weight Reduction Diet,Diet, Weight Loss,Diet, Weight Reduction,Diets, Reducing,Diets, Weight Loss,Diets, Weight Reduction,Reducing Diet,Reducing Diets,Weight Loss Diets,Weight Reduction Diets
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3

Related Publications

H Wilke, and B Regler, and R Keymling, and H Frahm
December 2016, Pharmacological research,
H Wilke, and B Regler, and R Keymling, and H Frahm
December 1975, Minerva medica,
H Wilke, and B Regler, and R Keymling, and H Frahm
June 1976, European journal of clinical pharmacology,
H Wilke, and B Regler, and R Keymling, and H Frahm
August 1973, Medizinische Klinik,
H Wilke, and B Regler, and R Keymling, and H Frahm
May 1982, Journal of the American Dietetic Association,
H Wilke, and B Regler, and R Keymling, and H Frahm
February 2000, Atherosclerosis,
H Wilke, and B Regler, and R Keymling, and H Frahm
January 1989, Cardiology,
H Wilke, and B Regler, and R Keymling, and H Frahm
April 1998, Cardiovascular drugs and therapy,
H Wilke, and B Regler, and R Keymling, and H Frahm
March 2011, The American journal of cardiology,
H Wilke, and B Regler, and R Keymling, and H Frahm
January 1980, Journal of medicine,
Copied contents to your clipboard!